序号 |
标题 |
次数 |
作者 |
发布时间 |
74791 |
Butyne-DOTA-tris(t-butyl ester),CAS: 2125661-54-1 |
148 |
h |
2024-12-16 |
74792 |
pAAV-PEG3-sTRAIL质粒 |
85 |
kx |
2024-12-16 |
74793 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
110 |
WYQ |
2024-12-16 |
74794 |
DOTA-PEG4-alkyne,CAS:2080307-47-5 |
68 |
h |
2024-12-16 |
74795 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
69 |
WYQ |
2024-12-16 |
74796 |
DOTA-NHS-ester,CAS:170908-81-3 |
59 |
h |
2024-12-16 |
74797 |
99Tcm-3PEG4-RGD |
102 |
kx |
2024-12-16 |
74798 |
Azido-PEG5-CH2CO2-t-Bu(CAS号:1448451-72-6) |
64 |
WYQ |
2024-12-16 |
74799 |
DOTA螯合剂DOTA-4AMP,CAS:254444-71-8 |
78 |
h |
2024-12-16 |
74800 |
Azido-PEG4-CH2CO2-t-Bu(CAS号:864681-04-9) |
66 |
WYQ |
2024-12-16 |
74801 |
alkoxyamine-PEG4-biotin ,烷氧基胺-四聚乙二醇-生物素 |
184 |
kx |
2024-12-16 |
74802 |
DOTA-CXCR4-L,DOTA-CXCR4靶向肽 |
105 |
h |
2024-12-16 |
74803 |
DOTA-Tetrazine,DOTA-四嗪 |
74 |
h |
2024-12-16 |
74804 |
Ag~(TS)-S(CH2)_(n-1)CH3// Ga2O3/EGaIn junctions,烷基链定制 |
137 |
wyh |
2024-12-16 |
74805 |
CMP-SA-PEG4-biotin的主要结构组成及功能 |
149 |
kx |
2024-12-16 |
74806 |
DOTA-Tetrazine,DOTA-四嗪 |
83 |
h |
2024-12-16 |
74807 |
Au25(SCH2CH2Ph)18,烷基链定制 |
97 |
wyh |
2024-12-16 |
74808 |
18F-AlF-NOTA-PEG4-ZD2 , 18F-AlF-1,4,7-三氮杂环壬烷-1,4,7-三乙酸-(聚乙二醇)4-ZD2 |
99 |
kx |
2024-12-16 |
74809 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
73 |
wyh |
2024-12-16 |
74810 |
Azido-PEG3-CH2CO2-t-Bu(CAS号:172531-36-1) |
99 |
WYQ |
2024-12-16 |
74811 |
mPEG113-b-P(MTC-Cholx-co-TMCy)x+y |
101 |
kx |
2024-12-16 |
74812 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
112 |
wyh |
2024-12-16 |
74813 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
80 |
WYQ |
2024-12-16 |
74814 |
DTPA(Gd)-PEG8-(FY)3 , DTPA(Gd)-聚乙二醇8-(FY)3 |
91 |
kx |
2024-12-16 |
74815 |
靶向CD45的抗体药物偶联物 |
110 |
kx |
2024-12-16 |
74816 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
71 |
WYQ |
2024-12-16 |
74817 |
抗体偶联药物的药物连接子MCMMAF |
99 |
kx |
2024-12-16 |
74818 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
60 |
WYQ |
2024-12-16 |
74819 |
全氟十四烷酸(PF;CF3(CF2)12COOH),烷基链定制 |
156 |
wyh |
2024-12-16 |
74820 |
靶向CD45的抗体药物偶联物 |
117 |
kx |
2024-12-16 |
74821 |
CH3(CH2)7COOH-CH3(CH2)7COO钠,烷基链定制 |
102 |
wyh |
2024-12-16 |
74822 |
HS(CH2)17CH3 ,十八硫醇,烷基链定制 |
138 |
wyh |
2024-12-16 |
74823 |
Fmoc-Val-Cit-PABC-Cn |
93 |
kx |
2024-12-16 |
74824 |
Mc-Val-Cit-PABOH ,组织蛋白酶B可切割 |
113 |
kx |
2024-12-16 |
74825 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
107 |
WYQ |
2024-12-16 |
74826 |
抗体偶联药物连接子Mc-Val-Cit-PABC-PNP |
106 |
kx |
2024-12-16 |
74827 |
NHS-d-PEG24-biotin |
134 |
kx |
2024-12-16 |
74828 |
β-agarase-BTPEG24-SA@MNPs , β-琼胶酶-生物素/链霉亲和素修饰的磁性纳米粒子 |
95 |
kx |
2024-12-16 |
74829 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
72 |
WYQ |
2024-12-16 |
74830 |
KYE28-PEG48 |
121 |
kx |
2024-12-16 |
74831 |
[(18)F]F-PEG(6)-IPQA PET示踪剂 |
118 |
kx |
2024-12-16 |
74832 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
83 |
WYQ |
2024-12-16 |
74833 |
HS-(CH2)17-CH3,1-十八硫醇,烷基链定制 |
81 |
wyh |
2024-12-16 |
74834 |
MePEG17-b-PCL5 ,甲氧基聚乙二醇-嵌段-聚己内酯 |
85 |
kx |
2024-12-16 |
74835 |
MAMA-(CH2)16COOH,烷基链定制 |
71 |
wyh |
2024-12-16 |